Kātao was founded with the primary aim of seeking early to mid-clinical stage life science investments in Israel (and Israeli related), guide them to maximize returns and improve health and well being.
Kātao enable entrepreneurs’ transition from research to market readiness through hands-on management and early-stage cooperation with prominent partners.